Dear Friends and Colleagues,
It gives me great pleasure to invite you to 2nd UAE’s International Conference on Antimicrobial Resistance (ICAMR) 2019, which will be held in Dubai, United Arab Emirates 21st to 22nd March 2019.
ICAMR 2019 promises you an enriching scientific and educational gathering, which will shed light on the latest advances in research and practice through presentations, workshops and interactive discussions with current, in-depth quality scientific contents in the field of Antimicrobial Resistance. The conference is organized by the National Committee of AMR in UAE.
We believe that the conference will provide an exceptional opportunity for everyone to share and acquire knowledge and experience on a wide spectrum of topics that are related to microbiology, infectious disease, infection control, and antimicrobial stewardship in addition to an opportunity to meet and rub shoulders with the experts in the field and innovative educators.
We look forward to welcoming you to ICAMR 2019.
Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai
Head of Central IPC Committee, MOHAP
National AMR Committee Co-Chair
Dubai, UAE
Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai
Head of Central IPC Committee, MOHAP
National AMR Committee Co-Chair
Dubai, UAE
Dr. Layla Al-Dabal
BSc, MD MSc (UK) FRCP (UK)
Consultant
Medical-Infectious Diseases
Rashid Hospital
Dubai, UAE
Dr. Khuloud Bin Rafeea
Senior Clinical Pharmacist
Pharmacy (Dep) – Pharmacy (Div)
Tawam Hospital
Al Ain, UAE
Dr. Ashraf El Houfi
Chairman of the Infection Control-
Committee Dubai Hospital
Consultant ICU
Dubai Hospital
Dubai, UAE
Prof. Hala Fouad Ismail
Consultant Microbiology & Immunology
Al Kuwait Hospital Laboratory
Pure Health
Dubai, UAE
Dr. Hamid Ragab Orban
Doctor of Veterinary Medicine (DVM)
Animal Production Specialist
Animal Wealth Sector
Abu Dhabi Food Control Authority (ADFCA)
Abu Dhabi, UAE
Dr. Manal Abdul Fattah Ahmed
Specialist microbiology
Umm Al Quwain, UAE
Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai
Head of Central IPC Committee, MOHAP
National AMR Committee Co-Chair
Dubai, UAE
Dr. Motasem Abuelreish
MD, ABP, ABPID
Consultant, Pediatric Infectious Diseases, AQWCH
Head, Infection Control Committee, AQWCH
Head, Antimicrobial Stewardship Team, AQWCH
Head, Central Antimicrobial Stewardship Team, MOHAP
Al Qassimi Women’s & Children’s Hospital
Sharjah, UAE
Dr. Layla Al-Dabal
BSc, MD MSc (UK) FRCP (UK)
Consultant
Medical-Infectious Diseases
Rashid Hospital
Dubai, UAE
Dr. Mubarak Alfaresi, MD
Head Of Pathology & Laboratory Medicine
Consultant Medical Microbiologist
Sheikh Khalifa General Hospital
Umm Al Quwain, UAE
Dr. Nawal Al Kaabi
Acting Chief Medical Officer
Pediatric Infectious Disease Consultant
Medical Institute – Medical Affairs
Sheikh Khalifa Medical City
Abu Dhabi, UAE
Dr. Khuloud Bin Rafeea
Senior Clinical Pharmacist
Pharmacy (Dep) – Pharmacy (Div)
Tawam Hospital
Al Ain, UAE
Dr. Ashraf El Houfi
Chairman of the
Infection Control-
Committee Dubai Hospital
Consultant ICU
Dubai Hospital
Dubai, UAE
Dr. Rania El-Lababidi
Pharm.D, EMHA,
BCPS (AQ-ID), AAHIVP
Senior Manager, Pharmacy Education and Training;
Co-Director, Antimicrobial Stewardship Program
Department of Pharmacy Services
Cleveland Clinic Abu Dhabi
Abu Dhabi, UAE
Prof. Hala Fouad Ismail
Consultant Microbiology & Immunology
Al Kuwait Hospital Dubai Laboratory
Pure Health
Dubai, UAE
Dr. Rayhan Hashmey
Adjunt Assoc. Prof. of Medicine, UAEU
Chief, General Internal Medicine,
Consultant Infectious Diseases
Tawam Hospital
Al Ain, UAE
Dr. Anju Nabi
Head of Microbiology &
Infection control Unit
DHA – Rashid Hospital
Dubai, UAE
Dr. Yousuf Mustafa Naqvi
Senior Officer,
Vaccines & Biologics
Health Regulation Division,
Regulatory Authority
Abu Dhabi, UAE
Dr. Ahmad Subhi
MD, Infectious Disease Doctor
Al Qassimi Hospital
Sharjah, UAE
Dr. Jens Thomsen
MD MPH
Consultant Clinical Microbiology
Chair, UAE National Sub-Committee for
Antimicrobial Resistance Surveillance
Section Head, Environmental Health
Occupational and Environmental Health Dept.
Dept. of Health (DoH)
Abu Dhabi, UAE
Dr. Dirar Abdallah
Consultant Internal Medicine, Intensivist
Head of ICU department.
Chair of Antibiotics Committee and (ASP).
Jordanian Board Internal Medicine
Member of UAE national ASP Committee.
Member of ESCMID & ESGAP
Prime Hospital
Dubai, UAE
Dr. Najiba M. Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai
Head of Central IPC Committee, MOHAP
National AMR Committee Co-Chair
Dubai, UAE
Dr. Layla Al-Dabal
BSc, MD MSc (UK) FRCP (UK)
Consultant
Medical-Infectious Diseases
Rashid Hospital
Dubai, UAE
Dr. Asim Alsaedi
Consultant, Infectious Diseases and Infection Control
Deputy, Associate Executive Director, Infection Prevention and Control
King Abdulaziz Medical City, Jeddah
NATIONAL GUARD HEALTH AFFAIRS
Asst. Professor, Internal Medicine and Infectious Diseases
King Saud bin Abdulaziz University for Health Sciences, Jeddah, KSA
Dr. Jameela AlSalman
Consultant in Infectious Diseases &
Consultant in Geriatric Medicine
Ministry of Health
Bahrain
Dr. Carole Ayoub
Associate Professor at Zayed University
College of Natural and Health Sciences
Zayed University
Dubai, UAE
Dr. Matteo Bassetti
Infectious Diseases Division
Santa Maria Misericordia
University Hospital
Udine, Italy
Dr. Khuloud Bin Rafeea
Senior Clinical Pharmacist
Pharmacy (Dep) – Pharmacy (Div)
Tawam Hospital
Al Ain, UAE
Dr. Nihar Dash
MD, DABMM, CIC
Chair Prevention and Control of Infection
Assistant Professor
University Hospital Sharjah
Sharjah, UAE
Dr. Rania El-Lababidi
Pharm.D, EMHA, BCPS (AQ-ID), AAHIVP
Senior Manager, Pharmacy Education and Training;
Co-Director, Antimicrobial Stewardship Program
Department of Pharmacy Services
Cleveland Clinic Abu Dhabi
Abu Dhabi, UAE
Prof. Hala Fouad Ismail
Consultant Microbiology & Immunology
Al Kuwait Hospital Dubai Laboratory
Pure Health
Dubai, UAE
Mr. Ahmed Ghatwary
Endoscopy Decontamination Consultant
Dubai,UAE
Ms. Helena Hrastnik
mag.oec., cleanroom specialist
Branch manager
Cleanroom Solutions
Dubai, UAE
Ms. Abeer Khalaf
APIC UAE president,
Chair of ICPCI conference
Prevention and Control of
Infection Manager – SKMC
Sheikh Khalifa Medical City
Abu Dhabi, UAE
Dr. Faryal Ali Khamis
Senior Consultant Adult Infectious-
Diseases & Clinical Microbiology
Chairperson, Infection Control &
Prevention Committee
Chairperson, Antimicrobial-
Stewardship Committee
The Royal Hospital
Ministry of Health
Muscat, Oman
Ms. Obaida Merheb
MS, MT, ASCP, CIC
Corporate Senior Infection-
Control Officer
Corporate Medical &
Clinical Affairs Division
Abu Dhabi Health Services Company
Abu Dhabi, UAE
Dr. Tibor Pal
MD, PhD, DSc
Professor of Microbiology,
Consultant Clinical Microbiologist
Medical Microbiology and Immunology
College of Medicine and Health Sci,
UAE University
Al Ain, UAE
Dr. Hamid Ragab Orban
Doctor of Veterinary Medicine (DVM)
Animal Production Specialist
Animal Wealth Sector
Abu Dhabi Food Control Authority (ADFCA)
Abu Dhabi, UAE
Ms. Abeer Rajeh
Head of Prevention and Control
of Infection Department,
Al Qassimi Hospital
Sharjah, UAE
Dr. Hariharan Saminathan
MD, B.V.Sc. & A.H., M.V.Sc.,
Ph.D. (Toxicology), DABT, ERT (UKRT)
Asst. Prof. of Veterinary Pharmacology & Toxicology
Veterinary Medicine
College of Food and Agriculture,
UAE University
Al Ain, UAE
Mr. Rohit Shetty
CEO
Consultancy
Dubai, UAE
Dr. Agnes Sonnevend-Pal
MD, PhD. Dr. med. habil
Associate Professor
Medical Microbiology and Immunology
College of Medicine and Health Sciences, UAEU
Al Ain, UAE
Dr. Maha Talaat
Regional Adviser
Antimicrobial Resistance & Infection Prevention and Control
Dept. of Communicable Diseases Prevention
World Health Organization
Regional Office for the Eastern Mediterranean
Cairo, Egypt
Dr. Jens Thomsen
MD MPH
Consultant Clinical Microbiology
Chair, UAE National Sub-Committee for
Antimicrobial Resistance Surveillance
Section Head, Environmental Health
Occupational and Environmental Health Dept.
Dept. of Health (DoH)
Abu Dhabi, UAE
Conference Highlights
- Regional and national AMR action plan
- Antimicrobial stewardship program
- Multidrug resistance organisms surveillance
- Infection Prevention and control program management
- Prevention of healthcare associated infections
- Occupational health issues for infection prevention
- Environmental disinfection in healthcare setting
- Advances in microbiology detection
- National reference laboratorye
- Role of IT in ASP
Target Specialities
- Infection disease physicians
- Internal medicine physicians
- Microbiologist
- Pharmacist
- Infection control practitioners
- Critical care physicians
- Lab technicians
- Quality officers
- Public health officers
- Internal Medicine Specialists
- Family and Primary Care Physicians
- Medical Informatics
- Nursing
- Nurses, Nurse Practitioners
- Researchers
- Biomedical Engineers
- Hospital and Corporate Administrators and Executives
Learning Objectives
- What is done to control AMR
- How to initiate ASP in low and high resources
- How to effectively manage infection control and prevention
- Prevent MDROs as part of patient safety goals
- How to change behavior of antibiotic prescribing
- Why is national reference laboratory required?
- Learn the best practices in prevention of HAIs
- How to prevent and deal with needle stick injuries
- Know the guidelines for environmental cleaning and disinfection in healthcare setting
- Quality improvement in infection control
- International accreditation and IPC/ASP
- Tuberculosis updates
- WHONET – Software for AMR Surveillance
You are invited to submit an abstract for the 2nd UAE’s International Conference on Antimicrobial Resistance (ICAMR) 2019 being held at the Le Meridien Dubai Hotel (Airport) & Conference Centre on 21st & 22nd March 2019.
Abstract submission deadline: 28th February 2019 – 11:59 PM
Notification on Acceptance/Rejection: 12th March 2019 – 11:59 PM
Please note that only electronic submissions are accepted.
Language
All abstracts must be submitted in English using the online submission form on the ICAMR website
General conditions
- Abstracts are required for all presentations.
- Abstracts must be submitted maximum by 28th February 2019 (23:59 GMT)
- Abstracts must be submitted in English.
- Withdrawal of abstracts can only be accepted if notified in writing. It is possible to withdraw an abstract 14 days after notification on acceptance.
- If selected, it is the responsibility of the presenter to bear his travel and accommodation expenses.
Presenting Author and Registration
- Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
- Disclosure: Abstract submitter and presenter are required to disclose any conflict of interest
- Ensure that all co-authors approve the abstract submission, publication, and potential presentation.
- All presenters should be registered to the conference before 1st March, 2019
- Abstract submitters must consent to the Policies of Abstract Submission
- Scientific committee reserves the right to exclude any abstract from the scientific program that is not followed by a participant registration at the latest 14 days after notification on acceptance
Contents of your abstract
-
- Original works and Case Reports about Critical Ultrasound / Point of Care Ultrasound will be accepted.
- The abstract text body is limited to 3,000 characters (Approx. 500 words) including spaces. (Please do not include the title and the author’s information in the text body (names and affiliations), this information will be required in the web form)
- The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.
- There are no limitations on the number of abstracts that an individual can submit. However, one individual can only present a maximum of 2 abstract (independent of the format) during the entire conference. If you have more than 2 abstracts accepted, you will be obliged to identify alternate presenters for any abstract above the first two.
- The abstract must include the following:
Aim: Clearly state the purpose of the abstract.
Methods: Describe your selection of observations or experimental subjects clearly.
Results: Presen, your results in a logical sequence in text, table and illustrations.
Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
- All abbreviations must be defined in first use.
- No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of the author(s) and their institution(s), when you submit your abstract online
- Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
- Use of brand names for all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. Conference scientific committee reserves the right to replace any brand name with a generic name without further notice.
- Images that are uploaded to follow the abstract are not guaranteed inclusion in the conference materials.
until 12th February, 2019 | 13th February - 12th March, 2019 | 13th March, 2019 onwards |
|
|---|---|---|---|
| Physicians | |||
| Non-Physicians, Nurses | |||
| Students | |||
| WHONET Workshop |
